Advanced glycation end products, carotid atherosclerosis, and circulating endothelial progenitor cells in patients with end-stage renal disease

Metabolism: Clinical and Experimental

Volumn 60, Issue 4, 2011, Pages 453-459

  Ueno, Hiroki ^a   Koyama, Hidenori ^a   Fukumoto, Shinya ^a   Tanaka, Shinji ^a   Shoji, Takuhito ^a   Shoji, Tetsuo ^a   Emoto, Masanori ^a   Tahara, Hideki ^a   Inaba, Masaaki ^a   Kakiya, Ryusuke ^b   Tabata, Tsutomu ^b   Miyata, Toshio ^c   Nishizawa, Yoshiki ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Inoue Hospital   (Japan)

^c TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CD133 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; HEMOGLOBIN; PENTOSIDINE; VASCULOTROPIN RECEPTOR 2;

ADULT; AGE; AGED; ARTERIAL WALL THICKNESS; ARTICLE; AUTOFLUORESCENCE; BLOOD LEVEL; CAROTID ATHEROSCLEROSIS; CELL COUNT; DIABETES MELLITUS; ENDOTHELIAL PROGENITOR CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENDER; HEMODIALYSIS PATIENT; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN CELL; INTRAVASCULAR ULTRASOUND; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PENTOSIDINE BLOOD LEVEL; PRIORITY JOURNAL; SKIN ABSORPTION; SKIN AUTOFLUORESCENCE;

AGED; ARGININE; CAROTID ARTERY DISEASES; CROSS-LINKING REAGENTS; ENDOTHELIAL CELLS; FEMALE; FLOW CYTOMETRY; FLUORESCENCE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; KIDNEY FAILURE, CHRONIC; LYSINE; MALE; MIDDLE AGED; REGRESSION ANALYSIS; SKIN PHYSIOLOGICAL PHENOMENA; STEM CELLS;

EID: 79952985492     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2010.04.001     Document Type: Article

References (52)

1. Asahara T., Murohara T., and Sullivan A. Isolation of putative progenitor endothelial cells for angiogenesis Science 275 1997 964 967 (Pubitemid 27087709)
2. Rafii S., and Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration Nat Med 9 2003 702 712 (Pubitemid 36749219)
3. Rauscher F.M., Goldschmidt-Clermont P.J., and Davis B.H. Aging, progenitor cell exhaustion, and atherosclerosis Circulation 108 2003 457 463 (Pubitemid 36935540)
4. Takahashi T., Kalka C., and Masuda H. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization Nat Med 5 1999 434 438 (Pubitemid 29180584)
5. Shintani S., Murohara T., and Ikeda H. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction Circulation 103 2001 2776 2779 (Pubitemid 32550062)
6. Gill M., Dias S., and Hattori K. Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells Circ Res 88 2001 167 174 (Pubitemid 32147304)
7. Vasa M., Fichtlscherer S., and Aicher A. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease Circ Res 89 2001 E1 E7
8. Hill J.M., Zalos G., and Halcox J.P. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk N Engl J Med 348 2003 593 600 (Pubitemid 36204953)
9. Schmidt-Lucke C., Rossig L., and Fichtlscherer S. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair Circulation 111 2005 2981 2987 (Pubitemid 40814192)
10. Haffner S.M., Lehto S., Ronnemaa T., Pyorala K., and Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction NEngl J Med 339 1998 229 234 (Pubitemid 28350165)
11. Go A.S., Chertow G.M., Fan D., McCulloch C.E., and Hsu C.Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization N Engl J Med 351 2004 1296 1305
12. Choi J.H., Kim K.L., and Huh W. Decreased number and impaired angiogenic function of endothelial progenitor cells in patients with chronic renal failure Arterioscler Thromb Vasc Biol 24 2004 1246 1252 (Pubitemid 38880016)
13. de Groot K., Bahlmann F.H., and Sowa J. Uremia causes endothelial progenitor cell deficiency Kidney Int 66 2004 641 646 (Pubitemid 38982006)
14. Herbrig K., Pistrosch F., and Oelschlaegel U. Increased total number but impaired migratory activity and adhesion of endothelial progenitor cells in patients on long-term hemodialysis Am J Kidney Dis 44 2004 840 849 (Pubitemid 39445916)
15. Schlieper G., Hristov M., and Brandenburg V. Predictors of low circulating endothelial progenitor cell numbers in haemodialysis patients Nephrol Dial Transplant 23 2008 2611 2618
16. Ueno H., Koyama H., and Fukumoto S. Dialysis modality is independently associated with circulating endothelial progenitor cells in end-stage renal diseases patients Nephrol Dial Transplant 25 2010 581 586
17. Tepper O.M., Galiano R.D., and Capla J.M. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures Circulation 106 2002 2781 2786 (Pubitemid 35396976)
18. Fadini G.P., Sartore S., Agostini C., and Avogaro A. Significance of endothelial progenitor cells in subjects with diabetes Diabetes Care 30 2007 1305 1313 (Pubitemid 46684670)
19. Scheubel R.J., Zorn H., and Silber R.E. Age-dependent depression in circulating endothelial progenitor cells in patients undergoing coronary artery bypass grafting J Am Coll Cardiol 42 2003 2073 2080 (Pubitemid 37549887)
20. Heiss C., Keymel S., and Niesler U. Impaired progenitor cell activity in age-related endothelial dysfunction J Am Coll Cardiol 45 2005 1441 1448 (Pubitemid 40615616)
21. Brownlee M. Advanced protein glycosylation in diabetes and aging Annu Rev Med 46 1995 223 234
22. Vishwanath V., Frank K.E., Elmets C.A., Dauchot P.J., and Monnier V.M. Glycation of skin collagen in type I diabetes mellitus. Correlation with long-term complications Diabetes 35 1986 916 921 (Pubitemid 16014445)
23. McCance D.R., Dyer D.G., and Dunn J.A. Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus J Clin Invest 91 1993 2470 2478 (Pubitemid 23182498)
24. Beisswenger P.J., Makita Z., and Curphey T.J. Formation of immunochemical advanced glycosylation end products precedes and correlates with early manifestations of renal and retinal disease in diabetes Diabetes 44 1995 824 829
25. Miyata T., van Ypersele de Strihou C., Kurokawa K., and Baynes J.W. Alterations in nonenzymatic biochemistry in uremia: origin and significance of "carbonyl stress" in long-term uremic complications Kidney Int 55 1999 389 399 (Pubitemid 29082866)
26. Meerwaldt R., Graaff R., and Oomen P.H. Simple non-invasive assessment of advanced glycation endproduct accumulation Diabetologia 47 2004 1324 1330 (Pubitemid 39093330)
27. Koyama H., Shoji T., and Fukumoto S. Low circulating endogenous secretory receptor for AGEs predicts cardiovascular mortality in patients with end-stage renal disease Arterioscler Thromb Vasc Biol 27 2007 147 153 (Pubitemid 46360392)
28. Ueno H., Koyama H., and Tanaka S. Skin autofluorescence, a marker for advanced glycation end product accumulation, is associated with arterial stiffness in patients with end-stage renal disease Metabolism 57 2008 1452 1457
29. Kawagishi T., Nishizawa Y., and Konishi T. High-resolution B-mode ultrasonography in evaluation of atherosclerosis in uremia Kidney Int 48 1995 820 826
30. Koyama H., Maeno T., and Fukumoto S. Platelet P-selectin expression is associated with atherosclerotic wall thickness in carotid artery in humans Circulation 108 2003 524 529 (Pubitemid 36961164)
31. Nienhuis H.L., de Leeuw K., and Bijzet J. Skin autofluorescence is increased in systemic lupus erythematosus but is not reflected by elevated plasma levels of advanced glycation endproducts Rheumatology (Oxford) 47 2008 1554 1558
32. Peichev M., Naiyer A.J., and Pereira D. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors Blood 95 2000 952 958 (Pubitemid 30062717)
33. Kondo T., Hayashi M., and Takeshita K. Smoking cessation rapidly increases circulating progenitor cells in peripheral blood in chronic smokers Arterioscler Thromb Vasc Biol 24 2004 1442 1447 (Pubitemid 39050438)
34. Gehling U.M., Ergun S., and Schumacher U. In vitro differentiation of endothelial cells from AC133-positive progenitor cells Blood 95 2000 3106 3112 (Pubitemid 30321161)
35. Reyes M., Dudek A., and Jahagirdar B. Origin of endothelial progenitors in human postnatal bone marrow J Clin Invest 109 2002 337 346 (Pubitemid 34141807)
36. Kocak H., Gumuslu S., and Ermis C. Oxidative stress and asymmetric dimethylarginine is independently associated with carotid intima media thickness in peritoneal dialysis patients Am J Nephrol 28 2008 91 96 (Pubitemid 350126498)
37. Yoshida N., Okumura K., and Aso Y. High serum pentosidine concentrations are associated with increased arterial stiffness and thickness in patients with type 2 diabetes Metabolism 54 2005 345 350 (Pubitemid 40250094)
38. Sibal L., Aldibbiat A., and Agarwal S.C. Circulating endothelial progenitor cells, endothelial function, carotid intima-media thickness and circulating markers of endothelial dysfunction in people with type 1 diabetes without macrovascular disease or microalbuminuria Diabetologia 52 2009 1464 1473
39. Fadini G.P., Coracina A., and Baesso I. Peripheral blood CD34+KDR+ endothelial progenitor cells are determinants of subclinical atherosclerosis in a middle-aged general population Stroke 37 2006 2277 2282 (Pubitemid 44337169)
40. Hughes A.D., Coady E., and Raynor S. Reduced endothelial progenitor cells in European and South Asian men with atherosclerosis Eur J Clin Invest 37 2007 35 41 (Pubitemid 44934770)
41. Tamarat R., Silvestre J.S., and Le Ricousse-Roussanne S. Impairment in ischemia-induced neovascularization in diabetes: bone marrow mononuclear cell dysfunction and therapeutic potential of placenta growth factor treatment Am J Pathol 164 2004 457 466 (Pubitemid 38364662)
42. Chavakis E., Hain A., and Vinci M. High-mobility group box 1 activates integrin-dependent homing of endothelial progenitor cells Circ Res 100 2007 204 212 (Pubitemid 46208720)
43. Scheubel R.J., Kahrstedt S., and Weber H. Depression of progenitor cell function by advanced glycation endproducts (AGEs): potential relevance for impaired angiogenesis in advanced age and diabetes Exp Gerontol 41 2006 540 548 (Pubitemid 43765896)
44. Koyama H., and Nishizawa Y. Cardiovascular complications in renal failure: implications of advanced glycation end-products and their receptor, RAGE T. Miyata, K.U. Eckardt, M. Nangaku, Oxidative stress in applied basic research and clinical practice 'renal disorders' 2010 The Humana Press/Springer Science New York [in press]
45. Hartog J.W., de Vries A.P., and Lutgers H.L. Accumulation of advanced glycation end products, measured as skin autofluorescence, in renal disease Ann N Y Acad Sci 1043 2005 299 307 (Pubitemid 41123919)
46. Lutgers H.L., Graaff R., and Links T.P. Skin autofluorescence as a noninvasive marker of vascular damage in patients with type 2 diabetes Diabetes Care 29 2006 2654 2659 (Pubitemid 44912194)
47. Meerwaldt R., Links T.P., and Graaff R. Increased accumulation of skin advanced glycation end-products precedes and correlates with clinical manifestation of diabetic neuropathy Diabetologia 48 2005 1637 1644 (Pubitemid 41175518)
48. Meerwaldt R., Hartog J.W., and Graaff R. Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients J Am Soc Nephrol 16 2005 3687 3693 (Pubitemid 46211290)
49. Meerwaldt R., Lutgers H.L., and Links T.P. Skin autofluorescence is a strong predictor of cardiac mortality in diabetes Diabetes Care 30 2007 107 112 (Pubitemid 46052507)
50. Blacher J., Guerin A.P., and Pannier B. Impact of aortic stiffness on survival in end-stage renal disease Circulation 99 1999 2434 2439 (Pubitemid 29218240)
51. Shoji T., Emoto M., and Shinohara K. Diabetes mellitus, aortic stiffness, and cardiovascular mortality in end-stage renal disease J Am Soc Nephrol 12 2001 2117 2124 (Pubitemid 32880348)
52. Koyama H., Yamamoto H., and Nishizawa Y. RAGE and soluble RAGE: potential therapeutic targets for cardiovascular diseases Mol Med 13 2007 625 635 (Pubitemid 350228723)